Binding specificities of actinomycin D to non-self-complementary -XGCY-tetranucleotide sequences

Area of Science:

• Molecular Biology
• Biochemistry
• Drug Discovery

Background:

• Actinomycin D (ACTD) is a chemotherapeutic agent known to intercalate into DNA.
• Understanding ACTD binding specificity to DNA sequences is crucial for developing targeted therapies.
• Previous studies focused on self-complementary tetranucleotide sequences.

Purpose of the Study:

• To investigate the binding specificity of actinomycin D (ACTD) to non-self-complementary tetranucleotide sequences of the form -XGCY-.
• To elucidate how base sequence alterations adjacent to GC sites affect ACTD binding affinity and dissociation kinetics.

Main Methods:

• Equilibrium, kinetic, and thermal denaturation studies were performed on decameric DNA duplexes.
• Specific non-self-complementary sequences (-XGCY-) were synthesized and analyzed.
• Binding constants, melting temperature changes, and drug dissociation rates (SDS-induced) were measured.
• Induced circular dichroism (CD) and fluorescence measurements were utilized.

Main Results:

• DNA sequences with G at the X position or C at the Y position (-XGCY-) exhibited significantly weaker ACTD binding affinities (0.6-2 µM⁻¹) compared to others (4-9 µM⁻¹).
• These sequences also showed smaller increases in melting temperature upon ACTD binding.
• ACTD dissociation rates were at least an order of magnitude faster for sequences with G or C at these positions.

Conclusions:

• Base sequence alterations adjacent to the GC site profoundly affect ACTD binding and dissociation characteristics.
• These effects are likely due to subtle conformational changes in the DNA near the binding site.
• Findings are consistent with studies on self-complementary sequences, reinforcing the impact of sequence context on drug-DNA interactions.